VTN and Alzheimer disease: In AD patients, cross-sectional and longitudinal studies found that A1 astrocytes, which produce inflammatory complement proteins of both the classical and alternative complement pathways in astrocyte-derived exosomes (ADEs), are increased in AD patients compared to controls [33].